Taken together, these findings suggest that increased expression of TPβ, or of TPα or a combination of TPα/TPβ expression levels, may serve as diagnostic biomarkers and clinical predictors of PCa disease recurrence. The gene discussed is PLAT; the disease is posterior cortical atrophy.